C.R. BARD, INC. (BASD) -3006260740 POWERLOC SAFETY INFUSION SET 19G X 1 IN WITH Y-SITE; SET, ADMINISTRATION, INTRAVASCULAR
|
Back to Search Results |
|
Model Number N/A |
Device Problems
Crack (1135); Fluid/Blood Leak (1250)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/08/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The manufacturer has received the sample and is pending evaluation.Results are expected soon.
|
|
Event Description
|
It was reported that there was a leak, around the y-site end area of the port tubing.Patient receiving immunotherapy and completed it, staff noticed leakage at the site prior to connecting to pump.Changed the entire port needle and no further leakage noted.Received medication from pump.No other information provided.Additional information received (b)(6) 2023: it was reported there is interruption of administration of medication/cause a clinically significant delay in medication that negatively impacted the patient.Patient did not receive all prescribed chemo for cancer regimen, patient was exposed to the chemo.Chemo exposure, no harm.
|
|
Event Description
|
It was reported that there was a leak, around the y-site end area of the port tubing.Patient receiving immunotherapy and completed it, staff noticed leakage at the site prior to connecting to pump.Changed the entire port needle and no further leakage noted.Received medication from pump.No other information provided.Additional information received 8/21/2023: it was reported there is interruption of administration of medication/cause a clinically significant delay in medication that negatively impacted the patient.Patient did not receive all prescribed chemo for cancer regimen, patient was exposed to the chemo.Chemo exposure, no harm.
|
|
Manufacturer Narrative
|
The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Based on a review of applicable information, the following was concluded: the complaint of a crack in the y-site was confirmed as supplier related.The returned sample was found to exhibit the same features as a known issue.The returned product was a 19g x 1¿ powerloc safety infusion set.The y-site luer adaptor contained a longitudinal crack traversed from the orifice of the connector to the mold indicator.The crack in the y-site luer adaptor leaked when the sample was flushed.This event was likely related to a known supplier related issue.This complaint will be recorded for future trending and monitoring purposes.
|
|
Search Alerts/Recalls
|
|
|